26
20
Brain Tumor Reports

Volume 17 Number 5
May 2017

Home > Publications > Brain Tumor Reports > Volume 17, Year 2017 > Number 5, May


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
MEDULLOBLASTOMA
OLIGODENDROGLIOMA
PILOCYTIC ASTROCYTOMA





BRAIN TUMORS



Al-Dorzi HM, Alruwaita AA, Marae BO, Alraddadi BS, Tamim HM, Ferayan A, Arabi YM.
Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection.
Neurosciences (Riyadh). 2017 Apr;22(2):107-113. doi: 10.17712/nsj.2017.2.20160570.
Source | Abstract | Full text | Similar articles




Bai RY, Staedtke V, Xia X, Riggins GJ.
Prevention of tumor seeding during needle biopsy by chemotherapeutic-releasing gelatin sticks.
Oncotarget. 2017 Feb 16. doi: 10.18632/oncotarget.15427. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Alvarado AG, Thiagarajan PS, Mulkearns-Hubert EE, Silver DJ, Hale JS, Alban TJ, Turaga SM, Jarrar A, Reizes O, Longworth MS, Vogelbaum MA, Lathia JD.
Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.
Cell Stem Cell. 2017 Apr 6;20(4):450-461.e4. doi: 10.1016/j.stem.2016.12.001. Epub 2017 Jan 12.
Source | Abstract | Full text | Similar articles




Anestis DM, Tsitsopoulos PP, Ble CA, Tsitouras V, Tsonidis CA.
Congenital Glioblastoma Multiforme: An Unusual and Challenging Tumor.
Neuropediatrics. 2017 Apr 11. doi: 10.1055/s-0037-1601858. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD.
Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
Sci Transl Med. 2017 Feb 1;9(375). pii: eaah6510. doi: 10.1126/scitranslmed.aah6510.
Source | Abstract | Full text | Similar articles




Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH.
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057.
Source | Abstract | Full text | Similar articles




Finocchiaro G.
TLRgeting Evasion of Immune Pathways in Glioblastoma.
Cell Stem Cell. 2017 Apr 6;20(4):422-424. doi: 10.1016/j.stem.2017.03.018.
Source | Abstract | Full text | Similar articles




Foro Arnalot P, Pera O, Rodriguez N, Sanz X, Reig A, Membrive I, Ortiz A, Granados R, Algara M.
Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
Clin Transl Oncol. 2017 Apr 7. doi: 10.1007/s12094-017-1659-5. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Grossman SA, Schreck KC, Ballman K, Alexander B.
Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.
Neuro Oncol. 2017 Apr 1;19(4):469-474. doi: 10.1093/neuonc/nox030.
Source | Abstract | Full text | Similar articles




Howard SP, Krauze A, Chan MD, Tsien C, Tomé WA.
The evolving role for re-irradiation in the management of recurrent grade 4 glioma.
J Neurooncol. 2017 Apr 6. doi: 10.1007/s11060-017-2392-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hutchinson L.
CNS cancer: New chemoradiation standard for elderly patients with glioblastoma.
Nat Rev Clin Oncol. 2017 Apr 11. doi: 10.1038/nrclinonc.2017.54. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kesari S, Ram Z; EF-14 Trial Investigators.
Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
CNS Oncol. 2017 Apr 12. doi: 10.2217/cns-2016-0049. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mutukula N, Elkabetz Y.
"Neural Killer" Cells: Autologous Cytotoxic Neural Stem Cells for Fighting Glioma.
Cell Stem Cell. 2017 Apr 6;20(4):426-428. doi: 10.1016/j.stem.2017.03.019.
Source | Abstract | Full text | Similar articles




Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP; Trial Investigators.
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
N Engl J Med. 2017 Mar 16;376(11):1027-1037. doi: 10.1056/NEJMoa1611977.
Source | Abstract | Full text | Similar articles




Qazi MA, Vora P, Venugopal C, Sidhu SS, Moffat J, Swanton C, Singh SK.
Intratumoral Heterogeneity: Pathways to Treatment Resistance and Relapse in Human Glioblastoma.
Ann Oncol. 2017 Apr 12. doi: 10.1093/annonc/mdx169. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Shen CX, Wu JF, Zhao W, Cai ZW, Cai RZ, Chen CM.
Primary spinal glioblastoma multiforme: A case report and review of the literature.
Medicine (Baltimore). 2017 Apr;96(16):e6634. doi: 10.1097/MD.0000000000006634.
Source | Abstract | Full text | Similar articles




Wen PY, Jiang T, Schiff D.
How can we develop therapies for glioblastoma more efficiently? Randomized versus single-arm studies.
Neuro Oncol. 2017 Apr 1;19(4):459-460. doi: 10.1093/neuonc/nox041.
Source | Abstract | Full text | Similar articles





GLIOMAS



Carlberg M, Hardell L.
Evaluation of Mobile Phone and Cordless Phone Use and Glioma Risk Using the Bradford Hill Viewpoints from 1965 on Association or Causation.
Biomed Res Int. 2017;2017:9218486. doi: 10.1155/2017/9218486. Epub 2017 Mar 16.
Source | Abstract | Full text | Similar articles




Lin AL, DeAngelis LM.
Reappraising the 2016 WHO classification for diffuse glioma.
Neuro Oncol. 2017 Apr 3. doi: 10.1093/neuonc/nox003. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




BRAIN STEM GLIOMAS


Diffuse intrinsic pontine gliomas


Lapin DH, Tsoli M, Ziegler DS.
Genomic Insights into Diffuse Intrinsic Pontine Glioma.
Front Oncol. 2017 Mar 28;7:57. doi: 10.3389/fonc.2017.00057. eCollection 2017.
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Noiphithak R, Veerasarn K.
Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute.
Asian J Neurosurg. 2017 Jan-Mar;12(1):28-33. doi: 10.4103/1793-5482.148791.
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Barresi V, Lionti S, Valori L, Gallina G, Caffo M, Rossi S.
Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?
J Neuropathol Exp Neurol. 2017 Apr 17. doi: 10.1093/jnen/nlx024. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Schupper AJ, Hirshman BR, Carroll KT, Ali MA, Carter BS, Chen CC.
Effect of gross total resection (GTR) in WHO grade II astrocytomas: A SEER based survival analysis.
World Neurosurg. 2017 Apr 15. pii: S1878-8750(17)30463-1. doi: 10.1016/j.wneu.2017.03.140. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wijnenga MM, Mattni T, French PJ, Rutten GJ, Leenstra S, Kloet F, Taphoorn MJ, van den Bent MJ, Dirven CM, van Veelen ML, Vincent AJ.
Does early resection of presumed low-grade glioma improve survival? A clinical perspective.
J Neurooncol. 2017 Apr 11. doi: 10.1007/s11060-017-2418-8. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Archer TC, Mahoney EL, Pomeroy SL.
Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Neurotherapeutics. 2017 Apr;14(2):265-273. doi: 10.1007/s13311-017-0526-y.
Source | Abstract | Full text | Similar articles




Fay-McClymont TB, Ploetz DM, Mabbott D, Walsh K, Smith A, Chi SN, Wells E, Madden J, Margol A, Finlay J, Kieran MW, Strother D, Dhall G, Packer RJ, Foreman NK, Bouffet E, Lafay-Cousin L.
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.
J Neurooncol. 2017 Apr 12. doi: 10.1007/s11060-017-2409-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Morrissy AS, Cavalli FMG, Remke M, Ramaswamy V, Shih DJH, Holgado BL, Farooq H, Donovan LK, Garzia L, Agnihotri S, Kiehna EN, Mercier E, Mayoh C, Papillon-Cavanagh S, Nikbakht H, Gayden T, Torchia J, Picard D, Merino DM, Vladoiu M, Luu B, Wu X, Daniels C, Horswell S, Thompson YY, Hovestadt V, Northcott PA, Jones DTW, Peacock J, Wang X, Mack SC, Reimand J, Albrecht S, Fontebasso AM, Thiessen N, Li Y, Schein JE, Lee D, Carlsen R, Mayo M, Tse K, Tam A, Dhalla N, Ally A, Chuah E, Cheng Y, Plettner P, Li HI, Corbett RD, Wong T, Long W, Loukides J, Buczkowicz P, Hawkins CE, Tabori U, Rood BR, Myseros JS, Packer RJ, Korshunov A, Lichter P, Kool M, Pfister SM, Schüller U, Dirks P, Huang A, Bouffet E, Rutka JT, Bader GD, Swanton C, Ma Y, Moore RA, Mungall AJ, Majewski J, Jones SJM, Das S, Malkin D, Jabado N, Marra MA, Taylor MD.
Spatial heterogeneity in medulloblastoma.
Nat Genet. 2017 Apr 10. doi: 10.1038/ng.3838. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Radhakrishnan V, Perumal J, Sundersingh S, Sagar T.
Lomustine induced acute pulmonary toxicity in a pediatric medulloblastoma survivor.
South Asian J Cancer. 2017 Jan-Mar;6(1):38-39. doi: 10.4103/2278-330X.202570.
Source | Abstract | Full text | Similar articles





OLIGODENDROGLIOMA



Achey RL, Khanna V, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.
Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.
J Neurooncol. 2017 Apr 10. doi: 10.1007/s11060-017-2414-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





PILOCYTIC ASTROCYTOMA



Sexton-Oates A, Dodgshun A, Hovestadt V, Jones DT, Ashley DM, Sullivan M, MacGregor D, Saffery R.
Methylation profiling of paediatric pilocytic astrocytoma reveals variants specifically associated with tumour location and predictive of recurrence.
Mol Oncol. 2017 Apr 7. doi: 10.1002/1878-0261.12062. [Epub ahead of print]
Source | Abstract | Full text | Similar articles